AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca performance Share Plan (PSP) — Unvested awards outstanding over Ordinary Shares (shares)
Form 20-F Note 29 — Employee Share-Based Payment Plans (Inline XBRL)
Latest, FY2025
3,390
Period ended Dec 31, 2025
Change on a year earlier
-5.1%
3,571 in FY2024
History
7 years
Since FY2019
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Performance Share Plan (PSP) — Unvested awards outstanding over Ordinary Shares (shares) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,390 | -5.1% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | 3,571 | -2.0% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | 3,645 | +0.4% | Form 20-F FY2025 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | 3,630 | +4.9% | Form 20-F FY2025 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | 3,459 | +13.6% | Form 20-F FY2024 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | 3,045 | +6.5% | Form 20-F FY2023 Annual Report ↗ |
| FY2019 | Dec 31, 2019 | 2,859 | – | Form 20-F FY2023 Annual Report ↗ |
Breakdown
What makes up performance share plan (psp) — unvested awards outstanding over ordinary shares (shares)
- PSP — Awards granted during year over Ordinary Shares (shares)904 · FY2025
- PSP — Grant-date weighted average fair value per Ordinary Share ($)111 · FY2025
- PSP — Unvested awards outstanding over ADSs (ADSs)5,790 · FY2025
- PSP — Awards granted during year over ADSs (ADSs)1,974 · FY2025
- PSP — Grant-date weighted average fair value per ADS ($)70.34 · FY2025
- Global Restricted Stock Plan (GRSP) — Awards outstanding over Ordinary Shares (shares)2,934 · FY2025
- GRSP — Awards granted over Ordinary Shares (shares)1,045 · FY2025
- GRSP — Awards outstanding over ADSs (ADSs)16,169 · FY2025
- GRSP — Awards granted over ADSs (ADSs)6,428 · FY2025
- Restricted Share Plan (RSP) — Awards outstanding over Ordinary Shares (shares)489 · FY2025
- RSP — Awards outstanding over ADSs (ADSs)886 · FY2025
- Executive Annual Bonus Deferred Share Plan — Awards outstanding (shares)162 · FY2025
Cite this data
StockData. (2026). AstraZeneca Performance Share Plan (PSP) — Unvested awards outstanding over Ordinary Shares (shares), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/sbc_out_psp_ord
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.